Cargando…

Angiotensin II type 2 receptor agonist Compound 21 attenuates pulmonary inflammation in a model of acute lung injury

PURPOSE: Although the role of the angiotensin II type 2 (AT2) receptor in acute lung injury is not yet completely understood, a protective role of this receptor subtype has been suggested. We hypothesized that, in a rodent model of acute lung injury, stimulation of the AT2 receptor with the direct a...

Descripción completa

Detalles Bibliográficos
Autores principales: Menk, Mario, Graw, Jan Adriaan, von Haefen, Clarissa, Steinkraus, Hendrik, Lachmann, Burkhard, Spies, Claudia D, Schwaiberger, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5935084/
https://www.ncbi.nlm.nih.gov/pubmed/29750051
http://dx.doi.org/10.2147/JIR.S160573
_version_ 1783320242220433408
author Menk, Mario
Graw, Jan Adriaan
von Haefen, Clarissa
Steinkraus, Hendrik
Lachmann, Burkhard
Spies, Claudia D
Schwaiberger, David
author_facet Menk, Mario
Graw, Jan Adriaan
von Haefen, Clarissa
Steinkraus, Hendrik
Lachmann, Burkhard
Spies, Claudia D
Schwaiberger, David
author_sort Menk, Mario
collection PubMed
description PURPOSE: Although the role of the angiotensin II type 2 (AT2) receptor in acute lung injury is not yet completely understood, a protective role of this receptor subtype has been suggested. We hypothesized that, in a rodent model of acute lung injury, stimulation of the AT2 receptor with the direct agonist Compound 21 (C21) might have a beneficial effect on pulmonary inflammation and might improve pulmonary gas exchange. MATERIALS AND METHODS: Male adult rats were divided into a treatment group that received pulmonary lavage followed by mechanical ventilation (LAV, n=9), a group receiving pulmonary lavage, mechanical ventilation, and direct stimulation of the AT2 receptor with C21 (LAV+C21, n=9), and a control group that received mechanical ventilation only (control, n=9). Arterial blood gas analysis was performed every 30 min throughout the 240-min observation period. Lung tissue and plasma samples were obtained at 240 min after the start of mechanical ventilation. Protein content and surface activity of bronchoalveolar lavage fluid were assessed and the wet/dry-weight ratio of lungs was determined. Transcriptional and translational regulation of pro- and antiinflammatory cytokines IL-1β, tumor necrosis factor-alpha, IL-6, IL-10, and IL-4 was determined in lungs and in plasma. RESULTS: Pulmonary lavage led to a significant impairment of gas exchange, the formation of lung edema, and the induction of pulmonary inflammation. Protein content of lavage fluid was increased and contained washed-out surfactant. Direct AT2 receptor stimulation with C21 led to a significant inhibition of tumor necrosis factor-alpha and IL-6 expressions in the lungs, whereas the expressions of IL-1, IL-10, and IL-4 remained unchanged. During the 240-min observation period, AT2 receptor stimulation did not improve pulmonary gas exchange or lung edema. CONCLUSION: In this rodent model of acute lung injury after repeated pulmonary lavage, AT2 receptor stimulation attenuates pulmonary inflammation but does not improve gas exchange.
format Online
Article
Text
id pubmed-5935084
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-59350842018-05-10 Angiotensin II type 2 receptor agonist Compound 21 attenuates pulmonary inflammation in a model of acute lung injury Menk, Mario Graw, Jan Adriaan von Haefen, Clarissa Steinkraus, Hendrik Lachmann, Burkhard Spies, Claudia D Schwaiberger, David J Inflamm Res Original Research PURPOSE: Although the role of the angiotensin II type 2 (AT2) receptor in acute lung injury is not yet completely understood, a protective role of this receptor subtype has been suggested. We hypothesized that, in a rodent model of acute lung injury, stimulation of the AT2 receptor with the direct agonist Compound 21 (C21) might have a beneficial effect on pulmonary inflammation and might improve pulmonary gas exchange. MATERIALS AND METHODS: Male adult rats were divided into a treatment group that received pulmonary lavage followed by mechanical ventilation (LAV, n=9), a group receiving pulmonary lavage, mechanical ventilation, and direct stimulation of the AT2 receptor with C21 (LAV+C21, n=9), and a control group that received mechanical ventilation only (control, n=9). Arterial blood gas analysis was performed every 30 min throughout the 240-min observation period. Lung tissue and plasma samples were obtained at 240 min after the start of mechanical ventilation. Protein content and surface activity of bronchoalveolar lavage fluid were assessed and the wet/dry-weight ratio of lungs was determined. Transcriptional and translational regulation of pro- and antiinflammatory cytokines IL-1β, tumor necrosis factor-alpha, IL-6, IL-10, and IL-4 was determined in lungs and in plasma. RESULTS: Pulmonary lavage led to a significant impairment of gas exchange, the formation of lung edema, and the induction of pulmonary inflammation. Protein content of lavage fluid was increased and contained washed-out surfactant. Direct AT2 receptor stimulation with C21 led to a significant inhibition of tumor necrosis factor-alpha and IL-6 expressions in the lungs, whereas the expressions of IL-1, IL-10, and IL-4 remained unchanged. During the 240-min observation period, AT2 receptor stimulation did not improve pulmonary gas exchange or lung edema. CONCLUSION: In this rodent model of acute lung injury after repeated pulmonary lavage, AT2 receptor stimulation attenuates pulmonary inflammation but does not improve gas exchange. Dove Medical Press 2018-05-01 /pmc/articles/PMC5935084/ /pubmed/29750051 http://dx.doi.org/10.2147/JIR.S160573 Text en © 2018 Menk et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Menk, Mario
Graw, Jan Adriaan
von Haefen, Clarissa
Steinkraus, Hendrik
Lachmann, Burkhard
Spies, Claudia D
Schwaiberger, David
Angiotensin II type 2 receptor agonist Compound 21 attenuates pulmonary inflammation in a model of acute lung injury
title Angiotensin II type 2 receptor agonist Compound 21 attenuates pulmonary inflammation in a model of acute lung injury
title_full Angiotensin II type 2 receptor agonist Compound 21 attenuates pulmonary inflammation in a model of acute lung injury
title_fullStr Angiotensin II type 2 receptor agonist Compound 21 attenuates pulmonary inflammation in a model of acute lung injury
title_full_unstemmed Angiotensin II type 2 receptor agonist Compound 21 attenuates pulmonary inflammation in a model of acute lung injury
title_short Angiotensin II type 2 receptor agonist Compound 21 attenuates pulmonary inflammation in a model of acute lung injury
title_sort angiotensin ii type 2 receptor agonist compound 21 attenuates pulmonary inflammation in a model of acute lung injury
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5935084/
https://www.ncbi.nlm.nih.gov/pubmed/29750051
http://dx.doi.org/10.2147/JIR.S160573
work_keys_str_mv AT menkmario angiotensiniitype2receptoragonistcompound21attenuatespulmonaryinflammationinamodelofacutelunginjury
AT grawjanadriaan angiotensiniitype2receptoragonistcompound21attenuatespulmonaryinflammationinamodelofacutelunginjury
AT vonhaefenclarissa angiotensiniitype2receptoragonistcompound21attenuatespulmonaryinflammationinamodelofacutelunginjury
AT steinkraushendrik angiotensiniitype2receptoragonistcompound21attenuatespulmonaryinflammationinamodelofacutelunginjury
AT lachmannburkhard angiotensiniitype2receptoragonistcompound21attenuatespulmonaryinflammationinamodelofacutelunginjury
AT spiesclaudiad angiotensiniitype2receptoragonistcompound21attenuatespulmonaryinflammationinamodelofacutelunginjury
AT schwaibergerdavid angiotensiniitype2receptoragonistcompound21attenuatespulmonaryinflammationinamodelofacutelunginjury